Applications: IHC, IHC-P
Host: Rabbit Polyclonal
Applications: WB, Flow, ICC/IF
Host: Mouse Monoclonal
Applications: WB, ELISA, PA, AP
Docking proteins interact with receptor tyrosine kinases and mediate particular biological responses using signal transduction. DOK2 acts as a multiple docking protein downstream of receptor or non-receptor tyrosine kinases. By this mechanism it acts to negatively regulate signal transduction and cell proliferation controlled by cytokines in a feedback loop. DOK2 is highly expressed in cells and tissues of hematopoietic origin as well as in lung. Expression of bcr/abl induces additional tyrosine phosphorylation of the DOK1 and DOK2 proteins and their association with Ras-GAP. Thus, it is suspected that DOK association regulates GAP activity toward Ras and that the DOK proteins serve as mediators of bcr-abl signaling. The role of DOK proteins in bcr-abl regulation may also be implicated in chronic myelogenous leukemia (CML), which is characterized by a Philadelphia chromosome translocation t(9;22). Such a mutation would result in a p210-bcr/abl chimeric protein-tyrosine kinase which has been found in many CML cases.
|Product By Gene ID
- Downstream of tyrosine kinase 2
- docking protein 2
- docking protein 2, 56kD
- docking protein 2, 56kDa
Bioinformatics Tool for DOK2
Discover related pathways, diseases and genes to DOK2. Need help? Read the Bioinformatics Tool Guide
for instructions on using this tool.